These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 7589374

  • 1. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.
    Rutten-van Mölken MP, Custers F, van Doorslaer EK, Jansen CC, Heurman L, Maesen FP, Smeets JJ, Bommer AM, Raaijmakers JA.
    Eur Respir J; 1995 Jun; 8(6):888-98. PubMed ID: 7589374
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW, Casale TB, Murray JJ, Petrocella V, Cox F, Rickard K.
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, Rickard K.
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
    [Abstract] [Full Text] [Related]

  • 4. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

  • 5. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.
    Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A.
    Am J Respir Crit Care Med; 1995 Jan; 151(1):66-70. PubMed ID: 7812574
    [Abstract] [Full Text] [Related]

  • 6. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 7. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ, Søes-Petersen U, Christensen M, Iversen ET, Rasmussen FV.
    Ugeskr Laeger; 1996 Jul 01; 158(27):3940-3. PubMed ID: 8701511
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A.
    Ann Allergy Asthma Immunol; 1997 May 01; 78(5):457-64. PubMed ID: 9164358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.
    Ann Allergy Asthma Immunol; 1999 Feb 01; 82(2):205-11. PubMed ID: 10071526
    [Abstract] [Full Text] [Related]

  • 12. The correlation between asthma control and health status: the GOAL study.
    Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE.
    Eur Respir J; 2007 Jan 01; 29(1):56-62. PubMed ID: 17050557
    [Abstract] [Full Text] [Related]

  • 13. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS.
    Ann Allergy Asthma Immunol; 1995 Aug 01; 75(2):180-4. PubMed ID: 7648385
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 01; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 16. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW.
    N Engl J Med; 1992 Nov 12; 327(20):1420-5. PubMed ID: 1357554
    [Abstract] [Full Text] [Related]

  • 17. [The influence of salmeterol and salbutamol on bronchial constriction in patients with bronchial asthma].
    Tymińska K, Grzelewska-Rzymowska I, Kroczyńska-Bednarek J, Kwiatkowska S.
    Pneumonol Alergol Pol; 1998 Nov 12; 66(11-12):524-9. PubMed ID: 10391959
    [Abstract] [Full Text] [Related]

  • 18. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring.
    Kemp JP, Bierman CW, Cocchetto DM.
    Ann Allergy; 1993 Apr 12; 70(4):316-22. PubMed ID: 8466097
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 12; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.